期刊文献+

粘着斑蛋白、雄激素受体在前列腺癌中的表达及相关性研究 被引量:2

Vinculin and the androgen receptor in prostate cancer:Expressions and correlations
原文传递
导出
摘要 目的:检测粘着斑蛋白(VCL)和雄激素受体(AR)在良性前列腺增生(BPH)和前列腺癌(PCa)中的表达情况,并分析其与PCa不同临床分期、病理分级、PSA水平之间的相互关系。方法:采用免疫组化法检测18例BPH组织,38例PCa组织中VCL、AR的表达。并分析两者在BPH、PCa中的表达差异,在PCa不同临床分期、病理分级、初次PSA检测水平的表达差异,以及两者之间的相关性。结果:VCL在PCa中的表达较BPH组织增多,AR表达在BPH、PCa中无明显差异;VCL、AR在PCa组织中的表达与肿瘤临床分期、病理分级密切相关,与PSA值无明显关系;VCL、AR在PCa组织中的表达存在正相关。结论:VCL在BPH、PCa的表达具有差异性,可以作为前列腺良、恶性疾病鉴别诊断的一个潜在指标;AR、VCL随PCa进展表达逐步下降,两者存在正相关,两者结合可以成为PCa进展的诊断、预后评价指标。 Objective:To investigate the expressions of vinculin(VCL) and the androgen receptor(AR) in benign prostatic hyperplasia(BPH) and prostate cancer(PCa) and analyze their relationship with the clinical stage and pathological grade of PCa and the level of PSA.Methods:We detected the expressions of VCL and AR in 18 cases of BPH and 38 cases of PCa by immunohistochemistry,analyzed the differences of VCL and AR expressions in BPH and PCa in different clinical stages and pathological grades of PCa,compared the primary levels of PSA,and studied their correlations.Results:The positive rate of VCL was significantly higher in PCa than in BPH tissues(P〈0.05),while that of AR showed no significant differences between the two groups(P〈0.05).Both the expressions of VCL and AR were closely related with the clinical stage and pathological grade of PCa(P〈0.05),but not with the PSA level(P〈0.05).There was a positive correlation between the expressions of VCL and AR in PCa tissues(r = 0.489,P〈0.05).Conclusion:VCL is expressed differently in BPH and PCa,which may serve as an indicator for the differential diagnosis of benign and malignant prostate diseases.The expressions of AR and VCL are gradually reduced with the progression of PCa,with a positive correlation between them,and could be used jointly to evaluate the progression and prognosis of PCa.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2010年第9期794-798,共5页 National Journal of Andrology
关键词 前列腺癌 粘着斑蛋白 雄激素受体 免疫组化 prostate cancer vinculin androgen receptor immunohistochemistry
  • 相关文献

参考文献28

  • 1孙颖浩.我国前列腺癌的研究现状[J].中华泌尿外科杂志,2004,25(2):77-80. 被引量:356
  • 2Tammela T. Endocrine treatment of prostate cancer. J Steroid Biochem Mol Biol, 2004, 92(4) : 287-295.
  • 3钟狂飚,桂明,蒋先镇,朱利勇,何乐业.雄激素依赖及非依赖性前列腺癌细胞差异蛋白质组的初步研究[J].中国男科学杂志,2008,22(5):5-9. 被引量:1
  • 4Algaba F, Arce Y, Fernandez S, et al. Adhesion molecules expression as a potential marker of prostate cancer aggressivity. A TMA study of radical prostatectomy specimens. Arch Ital Urol Androl, 2006, 78(4) : 130-134.
  • 5Giwercman YL, Richthoff J, Lilja H, et al. Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence. Prostate, 2004, 59(3): 227-233.
  • 6Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by surviving predicts shorter survivial rates in colorectal cancer. Cancer Res, 1998, 58(22) : 5071-5074.
  • 7Robnett TJ, Whittington R, Malkowicz SB, et al. Long-term use of combined radiation therapy and hormonal therapy in the management of stage D1 prostate cancer. Int J Radiat Oncol Biol Phys, 2002, 53(5) : 1146-1151.
  • 8Weller PA, Ogryzko EP, Corben EB, et al. Complete sequence of human vinculin and assignment of the gene to chromosome 10. Proc Natl Acad Sci USA, 1990, 87(15) : 5667-5671.
  • 9Perez-Castineira JR, Lopez-Marques RL, Villalba JM, et al. Functional complementation of yeast cytosolic pyrophosphatase by bacterial and plant H^+ translocating pyrophosphatase. Proc Natl Acad Sci USA, 2002, 99(25) : 15914-15919.
  • 10Komberg A. Inorganic polyphosphate : A molecule of many functions. Prog Mol Subcell Biol, 1999, 23: 1-18.

二级参考文献50

  • 1赵子彦,栾杨,路方红,付越榕,谢毅,刘建平,韩凯,张秀芹,Yvan Touitou.老年人血清皮质醇水平与年龄、性别及疾病的相关性探讨[J].中国老年学杂志,2004,24(11):994-996. 被引量:7
  • 2邵常霞,项永兵,刘振伟,高静,孙璐,方茹蓉,阮志贤,高立峰,金凡,高玉堂.上海市区泌尿系统恶性肿瘤相对生存率分析[J].中国肿瘤临床,2005,32(6):321-324. 被引量:31
  • 3Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev 2004; 25(2): 276-308.
  • 4Jahtonen R, Bolton NJ, Konturri M, et al. Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands.Prostate 1983; 4:129-139.
  • 5Lu ML, Schneider MC, Zheng Y, et al. Caveolin - 1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001;276:13442-13451.
  • 6Sweat S D, Pacelli A, Bergstralh E J, et al. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer. J Urol 1999; 161: 1229- 1232.
  • 7Chodak G W, Kranc D M, Puy L A, et al. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J Urol 1992; 147: 798- 803.
  • 8Coffey RN, Watson RW, O'Neill AJ, et al. Androgen-mediated resistance to apoptosis. Prostate 2002; 53(4): 300-309.
  • 9Kinoshita H, Shi Y, Sandefur C, et al. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res 2000; 60:3623-3630.
  • 10Wang LG, Ossowski L, Ferrari AC. Overexpressed androgen receptor linked to P21WAF1 silencing may be responsible for androgn independence and resistance to apoptosis of a prostate cancer cell line. Cancer Res 2001; 61 (20): 7544-7551.

共引文献363

同被引文献5

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部